4.79
price up icon2.35%   0.11
after-market Dopo l'orario di chiusura: 4.81 0.02 +0.42%
loading

Larimar Therapeutics Inc Azioni (LRMR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
78.11%
49.50
27.79 31.19 31.29 18.26
Operating Income/Loss
78.11%
-49.50
-27.79 -31.19 -31.29 -18.26
Nonoperating Income/Loss
10.99%
1.787
1.61 1.907 2.469 2.765
Income/Loss From Continuing Operations Before Tax
82.23%
-47.71
-26.18 -29.28 -28.82 -15.50
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
82.23%
-47.71
-26.18 -29.28 -28.82 -15.50
Net Income/Loss
82.23%
-47.71
-26.18 -29.28 -28.82 -15.50
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
22.33%
78.32
64.03 63.96 0.8564 63.81
Diluted Average Shares
22.33%
78.32
64.03 63.96 0.8564 63.81
Basic Earnings Per Share
48.78%
-0.61
-0.41 -0.46 -0.46 -0.24
Diluted Earnings Per Share
48.78%
-0.61
-0.41 -0.46 -0.46 -0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):